Adjuvant holmium-166 radioembolization after radiofrequency ablation in early-stage hepatocellular carcinoma patients: a dose-finding study (HORA EST HCC trial)Pim Hendriks, Daphne D. D. Rietbergen, Arian R. van Erkel et al.|European Journal of Nuclear Medicine and Molecular Imaging|2024Cited by 8